Advancing the Science of Recruitment for Alzheimer’s Disease Clinical Trials

Co-led by ATRI’s Dr. Paul Aisen, the roundtable will convene stakeholders across the clinical trials ecosystem to share insights on progress made, remaining gaps, evidence-based recruitment strategies and best practices advancing recruitment for inclusive Alzheimer’s clinical trials.